Catalyst Wire Dossier Catalyst Wire Dossier

EnligHTN Generation 2 System

· Abbott Medical Devices
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EnligHTN Generation 2 System, covering 2019-02-04 to 2019-02-04. Get the full timeline:

Most recent: Clinical Trial Update: International First-in-Human Study of the EnligHTN Generation 2 System in Patients With Drug-resistant Uncontrolled Hypertension [NA]

See pricing